Programme

Details will follow shortly.

Patient and family perspectives — surviving status epilepticus and its impact on patients and families
Biomarkers of brain injury in status epilepticus — molecular, serum and cerebrospinal fluid markers of brain damage and neurodegeneration.
Advances in neuroimaging — MRI and perfusion imaging, including imaging of neonatal status epilepticus.
Early seizure treatment and prevention of status epilepticus — rapid intervention, drug delivery devices and alternative administration routes.
Status epilepticus in specific clinical settings — epilepsy, developmental and epileptic encephalopathies, neonates, stroke and traumatic brain injury.
EEG diagnosis and monitoring — neurophysiology, criteria for non-convulsive status epilepticus and rapid EEG in emergency care.
New treatments and acute management strategies — ketamine, neurosteroids, emerging antiseizure therapies and the timing of intubation